PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM
The OMIM Gene map presents the cytogenetic map location of disease genes and other expressed genes described in OMIM. See the OMIM Morbid Map for a list of disease genes organized by disease. For more refined maps of genes and DNA segments click on the Location to invoke NCBI Entrez Map Viewer.
Search for: (from the current location)    
  • Enter gene symbol, chromosomal location, or disorder keyword to search for, e.g. "CYP1", "5", "1pter", "Xq", or "alzheimer".
  • You must capitalize X and Y to search for those chromosomes.
6p21.31, C6orf106 to 6p21.3, C4A <<Move Up Move Down>>
Location Symbol Title MIM # Disorder Comments Method Mouse
6p21.31 C6orf106 Chromosome 6 open reading frame 106   612217     REc  
6p21.31 PNPLA1 Patatin-like phospholipase domain-containing protein 1   612121     REc  
6p21.31 SNRPC Small nuclear ribonucleoprotein polypeptide C   603522     R, REc  
6p21.31 STQTL19 Stature quantitative trait locus 19   612893 {Stature QTL 19} (2) associated with rs1776897 Fd  
6p21.31 TAF11, TAF2I, TAFII28 TAF11 RNA polymerase II, TATA box-binding protein-associated factor, 28kD 600772     R, REc  
6p21.3 AGER, RAGE Advanced glycosylation end product-specific receptor   600214   at junction of classes II, III MHC RE, A  
6p21.3 AGPAT1, LPAATA 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase-alpha) 603099     REn  
6p21.3 ANKS1, ODIN, KIAA0229 Ankyrin repeat and sterile alpha motif domains-containing protein 1   608994     R, REc  
6p21.3 ATF6B, CREBL1 Activating transcription factor 6 beta   600984     REc  
6p21.3 ATP6V1G2, ATP6G ATPase, H+ transporting, lysosomal, 13kD, V1 subunit G isoform 2   606853     REc  
6p21.3 AZON Azoospremia, nonobstructive   606766 {Azoospremia, nonobstructive} (2)   Fd  
6p21.3 B3GALT4 UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 4 603095     REc, REn  
6p21.3 BAT1, D6S81E HLA-B associated transcript-1   142560   5 BATs in 160kb segment including also TNFA, TNFB RE  
6p21.3 BAT2, D6S51E HLA-B associated transcript-2   142580     RE  
6p21.3 BAT3, D6S52E HLA-B associated transcript-3   142590     RE  
6p21.3 BAT4, D6S54E HLA-B associated transcript-4   142610     RE  
6p21.3 BAT5, D6S82E HLA-B associated transcript-5   142620     RE  
6p21.3 BRD2, RING3, FSRG1 Bromodomain-containing protein 2   601540   between HLA-DNA and HLA-DMA REn, Fd  
6p21.3 BTNL2, SS2 Butyrophilin-like protein 2   606000 {Sarcoidosis, susceptibility to, 2}, 612387 (3)   REc  
6p21.3 C2 Complement component-2   217000 C2 deficiency (3); {Macular degeneration, age-related, reducedrisk of}, 603075 (3) no crossover with BF F, LD, RE 17(C2)
6p21.3 C4A, C4S Complement component-4A   120810 C4 deficiency (3); [Blood group, Rodgers] (2); {Systemic lupuserythematosus, susceptibility to or protection against}, 152700 (2) order: HLA-B, C2, BF, C4A, C4B, CYP21, DR F, H, RE, Fd 17(C4)
Copyright © 1966-2009 Johns Hopkins University <<Move Up Move Down>>

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH